Literature DB >> 32666290

The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.

Zhenwei Yang1,2, Mengna Zhang1,2, Ruyi Peng1,2, Jialong Liu1,2, Fan Wang1,2, Yizhang Li1,2, Qiu Zhao1,2, Jing Liu3,4.   

Abstract

PURPOSE: There is a growing literature on the significance of tumor-associated macrophages (TAMs) in colorectal cancer (CRC). However, the role of TAMs in predicting the prognosis of CRC remains controversial. The current study aims to determine the prognostic and clinicopathological value of different types and distribution of TAMs in CRC.
METHODS: A comprehensive literature search of PubMed, Embase, and Cochrane Library databases was conducted from the inception to 1 September 2019. The correlations of TAMs with overall survival (OS), disease-free survival (DFS), cancer-specific survival (CSS), and clinicopathological characteristics were analyzed.
RESULTS: A total of 5,575 patients from 29 studies were included in this meta-analysis. The pooled hazard ratios (HRs) indicated that high density of pan-macrophages in tumor invasive margin (IM) was associated with better OS (HR = 0.57, 95%CI = 0.38-0.85), DFS (HR = 0.32, 95%CI = 0.19-0.52), and CSS (HR = 0.56, 95%CI = 0.41-0.77). Moreover, the high density of pan-macrophages in tumor center (TC) was correlated with better DFS (HR = 0.66, 95%CI = 0.45-0.96). However, high expression of M2 macrophages in TC was associated with poor DFS (HR = 2.42, 95%CI = 1.45-4.07) and CSS (HR = 1.74, 95%CI = 1.24-2.44). High M2 macrophages density in IM was also associated with short DFS (HR = 2.81, 95%CI = 1.65-4.77). In addition, the results showed that high density of pan-macrophages in IM was associated with no tumor metastasis, while high M2 macrophages density in TC was correlated with poor tumor differentiation.
CONCLUSION: High Pan-TAMs density in IM has a positive effect on the prognosis of CRC patients, while high density M2 macrophage infiltration in TC is a strong indicator of poor prognosis.

Entities:  

Keywords:  Clinicopathological characteristics; Colorectal cancer; Meta-analysis; Prognosis; Tumor-associated macrophages

Mesh:

Year:  2020        PMID: 32666290     DOI: 10.1007/s00384-020-03686-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  10 in total

1.  Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.

Authors:  Kristine Aasebø; Jarle Bruun; Christian H Bergsland; Luís Nunes; Geir Egil Eide; Per Pfeiffer; Olav Dahl; Bengt Glimelius; Ragnhild A Lothe; Halfdan Sorbye
Journal:  Br J Cancer       Date:  2021-10-20       Impact factor: 9.075

2.  Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.

Authors:  Katsuaki Inagaki; Shoma Kunisho; Hidehiko Takigawa; Ryo Yuge; Shiro Oka; Shinji Tanaka; Fumio Shimamoto; Kazuaki Chayama; Yasuhiko Kitadai
Journal:  Cancer Sci       Date:  2021-06-02       Impact factor: 6.716

3.  Polarization of intestinal tumour-associated macrophages regulates the development of schistosomal colorectal cancer.

Authors:  Zijian Wang; Zhixiang Du; Haoyu Sheng; Xiuliang Xu; Wenjie Wang; Jian Yang; Jian Sun; Jianghua Yang
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

Review 4.  Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies.

Authors:  Nisha Kumari; Seung Hong Choi
Journal:  J Exp Clin Cancer Res       Date:  2022-02-19

Review 5.  Functional and Therapeutic Significance of Tumor-Associated Macrophages in Colorectal Cancer.

Authors:  Yitong Li; Zhenmei Chen; Jiahao Han; Xiaochen Ma; Xin Zheng; Jinhong Chen
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

6.  Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer.

Authors:  Tommaso Cavalleri; Luana Greco; Alberto Malesci; Luigi Laghi; Federica Rubbino; Tsuyoshi Hamada; Maria Quaranta; Fabio Grizzi; Elisabetta Sauta; Vincenzo Craviotto; Paola Bossi; Stefania Vetrano; Lorenza Rimassa; Valter Torri; Riccardo Bellazzi; Alberto Mantovani; Shuji Ogino
Journal:  J Pathol Clin Res       Date:  2022-03-23

Review 7.  Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance.

Authors:  Shaista Manzoor; Jibran Sualeh Muhammad; Azzam A Maghazachi; Qutayba Hamid
Journal:  Front Oncol       Date:  2022-07-14       Impact factor: 5.738

Review 8.  Colorectal Cancer and Purinergic Signalling: An Overview.

Authors:  Gabriela Gonçalves Roliano; Juliana Hofstätter Azambuja; Veronica Toniazzo Brunetto; Hannah Elizabeth Butterfield; Antonio Nochi Kalil; Elizandra Braganhol
Journal:  Cancers (Basel)       Date:  2022-10-06       Impact factor: 6.575

Review 9.  Turning enemies into allies-reprogramming tumor-associated macrophages for cancer therapy.

Authors:  Martina Molgora; Marco Colonna
Journal:  Med (N Y)       Date:  2021-06-15

10.  A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden.

Authors:  Zbigniew Starosolski; Amy N Courtney; Mayank Srivastava; Linjie Guo; Igor Stupin; Leonid S Metelitsa; Ananth Annapragada; Ketan B Ghaghada
Journal:  Contrast Media Mol Imaging       Date:  2021-06-14       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.